Multiple cycles of rituximab therapy for pemphigus: A group of patients with difficult‐ to‐treat disease or a consequence of late rituximab initiation?-Reference-Cited by-同舟云学术

Multiple cycles of rituximab therapy for pemphigus: A group of patients with difficult‐ to‐treat disease or a consequence of late rituximab initiation?

Published:2021-12-15 Issue:2 Volume:35 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Balighi Kamran¹²,Hatami Parvaneh¹^ORCID,Sheikh Aboli Mohammad Javad¹,Daneshpazhooh Maryam¹²,Ghiasi Maryam¹²,Mahmoudi Hamid Reza¹²^ORCID,Aryanian Zeinab¹³

Affiliation:

1. Autoimmune Bullous Diseases Research Center Tehran University of Medical Sciences Tehran Iran

2. Department of Dermatology, School of Medicine Razi Hospital Tehran University of Medical Sciences Tehran Iran

3. Department of Dermatology Babol University of Medical Sciences Babol Iran

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.15249

Reference16 articles.

1. Randomized trial of tacrolimus 0.1% ointment versus triamcinolone acetonide 0.1% paste in the treatment of oral pemphigus vulgaris. Iranian;Mohammad‐Javad N;J Dermatol,2012

2. A randomized trial of diphenylcyclopropenone (DPCP) combined with anthralin versus DPCP alone for treating moderate to severe alopecia areata

3. A prospective comparative study of two regimens of diphenylcyclopropenone (DPCP) in the treatment of alopecia areata

4. COVID vaccination in patients under treatment with rituximab: A presentation of two cases from Iran and a review of the current knowledge with a specific focus on pemphigus

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correlation between serum cardiac troponin I level and PDAI score in patients with pemphigus vulgaris;Archives of Dermatological Research;2024-07-11

2. Rituximab as a maintenance treatment in patients with pemphigus vulgaris: When is the right time for discontinuation?;Journal of Cosmetic Dermatology;2023-11-02

3. Combination therapy for management of pemphigus patients with unexpected therapeutic response to rituximab: A report of five cases;Clinical Case Reports;2023-11

4. A case report of esophageal cancer in a patient with pemphigus vulgaris: A coincidence or something beyond that?;Cancer Reports;2023-09-14

5. COVID outcome in pemphigus: Does rituximab make pemphigus patients susceptible to more severe COVID‐19?;Journal of Cosmetic Dermatology;2023-08-12